Delivery Order SPE2DB20D2001-SPE2DB25FPMNX
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$39K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,996,072 units of the diabetes medication Jardiance 25 mg tablets. The contract has a ceiling value of $25,342.73 and a period of performance through April 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,494.05 contract is for the supply of 4,567,951,867 units of the diabetes medication Jardiance 25 mg tablets. The award has an ultimate completion date of April 18, 2025 and was made on April 17, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,876.74, is for the delivery of 4,567,957,360 units of the diabetes medication Jardiance 25 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,906.81, is for the delivery of 4,567,957,203 units of the diabetes medication Jardiance 25 mg tablet with a completion date of April 18, 2025. This contract is not designated as a set-aside and is considered an open competition. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,369.07, is for the delivery of 4,568,077,683 units of the diabetes medication Jardiance 10 mg tablets. The contract has an ultimate completion date of April 30, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,057,960 units of the diabetes medication Jardiance 10 mg tablets in 90-count packages. The contract has a firm fixed price of $2,334.45 and a completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,931.70, is for the delivery of 4,567,874,185 units of the diabetes medication Jardiance 10 mg tablets. The award has an ultimate completion date of April 11, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,919,224 units of the diabetes medication Jardiance 25 mg tablets. The total ceiling value of the contract is $4,627.60, with a period of performance through April 16, 2025. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,872,065 units of the diabetes medication Jardiance 25 mg tablets in 90-count bottles. The contract has a ceiling value of $5,118.88 and an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,845,264 units of the diabetes medication Jardiance 25 mg tablets. The $15,239.66 firm fixed-price contract has a completion date of September 18, 2024. Amerisourcebergen, through its Corporate Office division, is a significant provider of pharmaceutical and medical supplies to the federal government, including military treatment facilities and...